Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uday Popat

Showing results (61-70 of 262) with videos related to

Pageof 27
Sort By:
Brain : a Journal of Neurology|October 3, 2007
Autologous HSCT for advanced MS: is the glass half-empty or really half-full?Richard A Nash, Olaf Stuve, James D Bowen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Blood Advances|November 10, 2020
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patientsBetül Oran, Marcos de Lima, Guillermo Garcia-Manero, et al.
Blood Advances|April 12, 2024
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignanciesSupawee Saengboon, Stefan Ciurea, Uday Popat, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2013
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infectionsDimpy P Shah, Shashank S Ghantoji, Jharna N Shah, et al.
Blood|December 16, 2010
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutationsElias Jabbour, Jorge Cortes, Fabio P S Santos, et al.
Cancer|January 26, 2025
Abuse potential and analgesic efficacy of intravenous hydromorphone bolus administration among hospitalized patients with cancer pain: A double-blind, double dummy, randomized crossover trialJoseph A Arthur, Akhila Reddy, Uday Popat, et al.
Leukemia & Lymphoma|June 1, 2026
Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoringTrevor Jamison, Elias Jabbour, Omer Karrar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 2010
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 lociStefan O Ciurea, Rima M Saliba, Gabriela Rondon, et al.
Pageof 27

Showing results (61-70 of 262) with videos related to

Sort By:
Pageof 27
Brain : a Journal of Neurology|October 3, 2007
Autologous HSCT for advanced MS: is the glass half-empty or really half-full?Richard A Nash, Olaf Stuve, James D Bowen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Blood Advances|November 10, 2020
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patientsBetül Oran, Marcos de Lima, Guillermo Garcia-Manero, et al.
Blood Advances|April 12, 2024
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignanciesSupawee Saengboon, Stefan Ciurea, Uday Popat, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2013
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infectionsDimpy P Shah, Shashank S Ghantoji, Jharna N Shah, et al.
Blood|December 16, 2010
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutationsElias Jabbour, Jorge Cortes, Fabio P S Santos, et al.
Cancer|January 26, 2025
Abuse potential and analgesic efficacy of intravenous hydromorphone bolus administration among hospitalized patients with cancer pain: A double-blind, double dummy, randomized crossover trialJoseph A Arthur, Akhila Reddy, Uday Popat, et al.
Leukemia & Lymphoma|June 1, 2026
Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoringTrevor Jamison, Elias Jabbour, Omer Karrar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 2010
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 lociStefan O Ciurea, Rima M Saliba, Gabriela Rondon, et al.
Pageof 27